User:Ewingdo/sandbox/list of cardiology clinical trials

Source: Wikipedia, the free encyclopedia.

Acute Coronary Syndrome / Coronary Artery Disease

Hypertension

Lipids

  • 4S Trial - multicenter, randomized, double-blind, placebo-controlled clinical trial that studied the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease.
  • AIM-HIGH Niacin for HDL levels[27]
  • CARDS
  • CORONA
  • ENHANCE
  • HATS - double-blind trial that studied people with coronary heart disease and compared a combination of simvastatin and niacin with antioxidant vitamin therapy.
  • HPS - randomized controlled trial that studied the use of the cholesterol lowering drug, simvastatin and vitamin supplementation in people who were at risk of cardiovascular disease.
  • IMPROVE-IT
  • JUPITER - clinical trial aimed at evaluating whether statins reduce heart attacks and strokes in people with normal cholesterol levels.
  • PROVE-IT TIMI 22 - randomized, double-blind, clinical trial that compared intensive vs. moderate dose statin therapy immediately after a heart attack.[28]
  • SATURN
  • WOSCOPS - randomized, double-blind, placebo-controlled clinical trial that compared the cholesterol lowering drug pravastatin in patients with no previous history of a heart attack.[29]

Heart Failure

Arrhythmias

Valvular diseases

  • PARTNER A – TAVR in high-risk patients
  • PARTNER 3 – TAVR in low-risk patients
  • COAPT – Transcatheter mitral valve repair
  • EASE – Surgery for infective endocarditis

See also

References

  1. ^ Maron, David J.; Hochman, Judith S.; Reynolds, Harmony R.; Bangalore, Sripal; O’Brien, Sean M.; Boden, William E.; Chaitman, Bernard R.; Senior, Roxy; López-Sendón, Jose; Alexander, Karen P.; Lopes, Renato D.; Shaw, Leslee J.; Berger, Jeffrey S.; Newman, Jonathan D.; Sidhu, Mandeep S.; Goodman, Shaun G.; Ruzyllo, Witold; Gosselin, Gilbert; Maggioni, Aldo P.; White, Harvey D.; Bhargava, Balram; Min, James K.; Mancini, G.B. John; Berman, Daniel S.; Picard, Michael H.; Kwong, Raymond Y.; Ali, Ziad A.; Mark, Daniel B.; Spertus, John A.; Krishnan, Mangalath N.; Elghamaz, Ahmed; Moorthy, Nagaraja; Hueb, Whady A.; Demkow, Marcin; Mavromatis, Kreton; Bockeria, Olga; Peteiro, Jesus; Miller, Todd D.; Szwed, Hanna; Doerr, Rolf; Keltai, Matyas; Selvanayagam, Joseph B.; Steg, P. Gabriel; Held, Claes; Kohsaka, Shun; Mavromichalis, Stavroula; Kirby, Ruth; Jeffries, Neal O.; Harrell, Frank E.; Rockhold, Frank W.; Broderick, Samuel; Ferguson, T. Bruce; Williams, David O.; Harrington, Robert A.; Stone, Gregg W.; Rosenberg, Yves (9 April 2020). "Initial Invasive or Conservative Strategy for Stable Coronary Disease". New England Journal of Medicine. 382 (15): 1395–1407. doi:10.1056/NEJMoa1915922.
  2. ^ Montalescot, Gilles; Bolognese, Leonardo; Dudek, Dariusz; Goldstein, Patrick; Hamm, Christian; Tanguay, Jean-Francois; ten Berg, Jurrien M.; Miller, Debra L.; Costigan, Timothy M.; Goedicke, Jochen; Silvain, Johanne; Angioli, Paolo; Legutko, Jacek; Niethammer, Margit; Motovska, Zuzana; Jakubowski, Joseph A.; Cayla, Guillaume; Visconti, Luigi Oltrona; Vicaut, Eric; Widimsky, Petr (12 September 2013). "Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes". New England Journal of Medicine. 369 (11): 999–1010. doi:10.1056/NEJMoa1308075.
  3. ^ Weintraub, William S.; Grau-Sepulveda, Maria V.; Weiss, Jocelyn M.; O'Brien, Sean M.; Peterson, Eric D.; Kolm, Paul; Zhang, Zugui; Klein, Lloyd W.; Shaw, Richard E.; McKay, Charles; Ritzenthaler, Laura L.; Popma, Jeffrey J.; Messenger, John C.; Shahian, David M.; Grover, Frederick L.; Mayer, John E.; Shewan, Cynthia M.; Garratt, Kirk N.; Moussa, Issam D.; Dangas, George D.; Edwards, Fred H. (19 April 2012). "Comparative Effectiveness of Revascularization Strategies". New England Journal of Medicine. 366 (16): 1467–1476. doi:10.1056/NEJMoa1110717.
  4. ^ Théroux, Pierre; Ouimet, Hélène; McCans, John; Latour, Jean-Gilles; Joly, Patrick; Lévy, Gilles; Pelletier, Edouard; Juneau, Martin; Stasiak, Jérôme; deGuise, Pierre; Pelletier, Guy B.; Rinzler, David; Waters, David D. (27 October 1988). "Aspirin, Heparin, or Both to Treat Acute Unstable Angina". New England Journal of Medicine. 319 (17): 1105–1111. doi:10.1056/NEJM198810273191701.
  5. ^ Mega, Jessica L.; Braunwald, Eugene; Wiviott, Stephen D.; Bassand, Jean-Pierre; Bhatt, Deepak L.; Bode, Christoph; Burton, Paul; Cohen, Marc; Cook-Bruns, Nancy; Fox, Keith A.A.; Goto, Shinya; Murphy, Sabina A.; Plotnikov, Alexei N.; Schneider, David; Sun, Xiang; Verheugt, Freek W.A.; Gibson, C. Michael (5 January 2012). "Rivaroxaban in Patients with a Recent Acute Coronary Syndrome". New England Journal of Medicine. 366 (1): 9–19. doi:10.1056/NEJMoa1112277.
  6. ^ Lopes, Renato D.; Heizer, Gretchen; Aronson, Ronald; Vora, Amit N.; Massaro, Tyler; Mehran, Roxana; Goodman, Shaun G.; Windecker, Stephan; Darius, Harald; Li, Jia; Averkov, Oleg; Bahit, M. Cecilia; Berwanger, Otavio; Budaj, Andrzej; Hijazi, Ziad; Parkhomenko, Alexander; Sinnaeve, Peter; Storey, Robert F.; Thiele, Holger; Vinereanu, Dragos; Granger, Christopher B.; Alexander, John H. (18 April 2019). "Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation". New England Journal of Medicine. 380 (16): 1509–1524. doi:10.1056/NEJMoa1817083.
  7. ^ Chaitman, Bernard R.; Rosen, Allan D.; Williams, David O.; Bourassa, Martial G.; Aguirre, Frank V.; Pitt, Bertram; Rautaharju, Pentti M.; Rogers, William J.; Sharaf, Barry; Attubato, Michael; Hardison, Regina M.; Srivatsa, Sanjay; Kouchoukos, Nicholas T.; Stocke, Karen; Sopko, George; Detre, Katherine; Frye, Robert (7 October 1997). "Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial". Circulation. 96 (7): 2162–2170. doi:10.1161/01.CIR.96.7.2162.
  8. ^ "A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease". New England Journal of Medicine. 360 (24): 2503–2515. 11 June 2009. doi:10.1056/NEJMoa0805796.
  9. ^ Kaiser, Christoph; Galatius, Soeren; Erne, Paul; Eberli, Franz; Alber, Hannes; Rickli, Hans; Pedrazzini, Giovanni; Hornig, Burkhard; Bertel, Osmund; Bonetti, Piero; De Servi, Stefano; Brunner-La Rocca, Hans-Peter; Ricard, Ingrid; Pfisterer, Matthias (9 December 2010). "Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries". New England Journal of Medicine. 363 (24): 2310–2319. doi:10.1056/NEJMoa1009406.
  10. ^ Sabatine, Marc S.; Cannon, Christopher P.; Gibson, C. Michael; López-Sendón, Jose L.; Montalescot, Gilles; Theroux, Pierre; Claeys, Marc J.; Cools, Frank; Hill, Karen A.; Skene, Allan M.; McCabe, Carolyn H.; Braunwald, Eugene (24 March 2005). "Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation". New England Journal of Medicine. 352 (12): 1179–1189. doi:10.1056/NEJMoa050522.
  11. ^ Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS (November 2005). "Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial". The Lancet. 366 (9497): 1622–1632. doi:10.1016/S0140-6736(05)67661-1.
  12. ^ Boden, William E.; O'Rourke, Robert A.; Teo, Koon K.; Hartigan, Pamela M.; Maron, David J.; Kostuk, William J.; Knudtson, Merril; Dada, Marcin; Casperson, Paul; Harris, Crystal L.; Chaitman, Bernard R.; Shaw, Leslee; Gosselin, Gilbert; Nawaz, Shah; Title, Lawrence M.; Gau, Gerald; Blaustein, Alvin S.; Booth, David C.; Bates, Eric R.; Spertus, John A.; Berman, Daniel S.; Mancini, G.B. John; Weintraub, William S. (12 April 2007). "Optimal Medical Therapy with or without PCI for Stable Coronary Disease". New England Journal of Medicine. 356 (15): 1503–1516. doi:10.1056/NEJMoa070829.
  13. ^ "Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation". New England Journal of Medicine. 345 (7): 494–502. 16 August 2001. doi:10.1056/NEJMoa010746.
  14. ^ Andersen, Henning R.; Nielsen, Torsten T.; Rasmussen, Klaus; Thuesen, Leif; Kelbaek, Henning; Thayssen, Per; Abildgaard, Ulrik; Pedersen, Flemming; Madsen, Jan K.; Grande, Peer; Villadsen, Anton B.; Krusell, Lars R.; Haghfelt, Torben; Lomholt, Preben; Husted, Steen E.; Vigholt, Else; Kjaergard, Henrik K.; Mortensen, Leif Spange (21 August 2003). "A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction". New England Journal of Medicine. 349 (8): 733–742. doi:10.1056/NEJMoa025142.
  15. ^ Farkouh, Michael E.; Domanski, Michael; Sleeper, Lynn A.; Siami, Flora S.; Dangas, George; Mack, Michael; Yang, May; Cohen, David J.; Rosenberg, Yves; Solomon, Scott D.; Desai, Akshay S.; Gersh, Bernard J.; Magnuson, Elizabeth A.; Lansky, Alexandra; Boineau, Robin; Weinberger, Jesse; Ramanathan, Krishnan; Sousa, J. Eduardo; Rankin, Jamie; Bhargava, Balram; Buse, John; Hueb, Whady; Smith, Craig R.; Muratov, Victoria; Bansilal, Sameer; King, Spencer; Bertrand, Michel; Fuster, Valentin (20 December 2012). "Strategies for Multivessel Revascularization in Patients with Diabetes". New England Journal of Medicine. 367 (25): 2375–2384. doi:10.1056/NEJMoa1211585.
  16. ^ "An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction". New England Journal of Medicine. 329 (10): 673–682. 2 September 1993. doi:10.1056/NEJM199309023291001.
  17. ^ Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (20 January 2000). "Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients". New England Journal of Medicine. 342 (3): 145–153. doi:10.1056/NEJM200001203420301.
  18. ^ "Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group". JAMA. 248 (12): 1465–77. 24 September 1982. PMID 7050440.
  19. ^ Gibson, C. Michael; Mehran, Roxana; Bode, Christoph; Halperin, Jonathan; Verheugt, Freek W.; Wildgoose, Peter; Birmingham, Mary; Ianus, Juliana; Burton, Paul; van Eickels, Martin; Korjian, Serge; Daaboul, Yazan; Lip, Gregory Y.H.; Cohen, Marc; Husted, Steen; Peterson, Eric D.; Fox, Keith A. (22 December 2016). "Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI". New England Journal of Medicine. 375 (25): 2423–2434. doi:10.1056/NEJMoa1611594.
  20. ^ Wallentin, Lars; Becker, Richard C.; Budaj, Andrzej; Cannon, Christopher P.; Emanuelsson, Håkan; Held, Claes; Horrow, Jay; Husted, Steen; James, Stefan; Katus, Hugo; Mahaffey, Kenneth W.; Scirica, Benjamin M.; Skene, Allan; Steg, Philippe Gabriel; Storey, Robert F.; Harrington, Robert A. (10 September 2009). "Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes". New England Journal of Medicine. 361 (11): 1045–1057. doi:10.1056/NEJMoa0904327.
  21. ^ Serruys, Patrick W.; Morice, Marie-Claude; Kappetein, A. Pieter; Colombo, Antonio; Holmes, David R.; Mack, Michael J.; Ståhle, Elisabeth; Feldman, Ted E.; van den Brand, Marcel; Bass, Eric J.; Van Dyck, Nic; Leadley, Katrin; Dawkins, Keith D.; Mohr, Friedrich W. (5 March 2009). "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease". New England Journal of Medicine. 360 (10): 961–972. doi:10.1056/NEJMoa0804626.
  22. ^ Mehta, Shamir R.; Granger, Christopher B.; Boden, William E.; Steg, Philippe Gabriel; Bassand, Jean-Pierre; Faxon, David P.; Afzal, Rizwan; Chrolavicius, Susan; Jolly, Sanjit S.; Widimsky, Petr; Avezum, Alvaro; Rupprecht, Hans-Jurgen; Zhu, Jun; Col, Jacques; Natarajan, Madhu K.; Horsman, Craig; Fox, Keith A.A.; Yusuf, Salim (21 May 2009). "Early versus Delayed Invasive Intervention in Acute Coronary Syndromes". New England Journal of Medicine. 360 (21): 2165–2175. doi:10.1056/NEJMoa0807986.
  23. ^ Antman, Elliott M.; Cohen, Marc; Bernink, Peter J. L. M.; McCabe, Carolyn H.; Horacek, Thomas; Papuchis, Gary; Mautner, Branco; Corbalan, Ramon; Radley, David; Braunwald, Eugene (16 August 2000). "The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making". JAMA. 284 (7): 835. doi:10.1001/jama.284.7.835.
  24. ^ Wiviott, Stephen D.; Braunwald, Eugene; McCabe, Carolyn H.; Montalescot, Gilles; Ruzyllo, Witold; Gottlieb, Shmuel; Neumann, Franz-Joseph; Ardissino, Diego; De Servi, Stefano; Murphy, Sabina A.; Riesmeyer, Jeffrey; Weerakkody, Govinda; Gibson, C. Michael; Antman, Elliott M. (15 November 2007). "Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes". New England Journal of Medicine. 357 (20): 2001–2015. doi:10.1056/NEJMoa0706482.
  25. ^ "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)". JAMA: The Journal of the American Medical Association. 288 (23): 2981–2997. 18 December 2002. doi:10.1001/jama.288.23.2981.
  26. ^ "A Randomized Trial of Intensive versus Standard Blood-Pressure Control". New England Journal of Medicine. 373 (22): 2103–2116. 26 November 2015. doi:10.1056/NEJMoa1511939.
  27. ^ Boden, William E; Probstfield, Jeffrey L; Anderson, Todd; Chaitman, Bernard R; Desvignes-Nickens, Patrice; Koprowicz, Kent; McBride, Ruth; Teo, Koon; Weintraub, William (15 December 2011). "Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy". New England Journal of Medicine. 365 (24): 2255–2267. doi:10.1056/nejmoa1107579.
  28. ^ Cannon, Christopher P.; Braunwald, Eugene; McCabe, Carolyn H.; Rader, Daniel J.; Rouleau, Jean L.; Belder, Rene; Joyal, Steven V.; Hill, Karen A.; Pfeffer, Marc A.; Skene, Allan M. (8 April 2004). "Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes". New England Journal of Medicine. 350 (15): 1495–1504. doi:10.1056/NEJMoa040583.
  29. ^ Shepherd, James; Cobbe, Stuart M.; Ford, Ian; Isles, Christopher G.; Lorimer, A. Ross; Macfarlane, Peter W.; McKillop, James H.; Packard, Christopher J. (16 November 1995). "Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia". New England Journal of Medicine. 333 (20): 1301–1308. doi:10.1056/NEJM199511163332001.
  30. ^ "The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure". New England Journal of Medicine. 336 (8): 525–533. 20 February 1997. doi:10.1056/NEJM199702203360801.
  31. ^ McMurray, John J.V.; Packer, Milton; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R. (11 September 2014). "Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure". New England Journal of Medicine. 371 (11): 993–1004. doi:10.1056/NEJMoa1409077.
  32. ^ "Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction". New England Journal of Medicine. 321 (6): 406–412. 10 August 1989. doi:10.1056/NEJM198908103210629.
  33. ^ Echt, Debra S.; Liebson, Philip R.; Mitchell, L. Brent; Peters, Robert W.; Obias-Manno, Dulce; Barker, Allan H.; Arensberg, Daniel; Baker, Andrea; Friedman, Lawrence; Greene, H. Leon; Huther, Melissa L.; Richardson, David W. (21 March 1991). "Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo: The Cardiac Arrhythmia Suppression Trial". New England Journal of Medicine. 324 (12): 781–788. doi:10.1056/NEJM199103213241201.
  34. ^ "Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction". New England Journal of Medicine. 327 (4): 227–233. 23 July 1992. doi:10.1056/NEJM199207233270403.
  35. ^ Marrouche, Nassir F.; Brachmann, Johannes; Andresen, Dietrich; Siebels, Jürgen; Boersma, Lucas; Jordaens, Luc; Merkely, Béla; Pokushalov, Evgeny; Sanders, Prashanthan; Proff, Jochen; Schunkert, Heribert; Christ, Hildegard; Vogt, Jürgen; Bänsch, Dietmar (February 2018). "Catheter Ablation for Atrial Fibrillation with Heart Failure". New England Journal of Medicine. 378 (5): 417–427. doi:10.1056/NEJMoa1707855.
  36. ^ Andrade, Jason G.; Wells, George A.; Deyell, Marc W.; Bennett, Matthew; Essebag, Vidal; Champagne, Jean; Roux, Jean-Francois; Yung, Derek; Skanes, Allan; Khaykin, Yaariv; Morillo, Carlos; Jolly, Umjeet; Novak, Paul; Lockwood, Evan; Amit, Guy; Angaran, Paul; Sapp, John; Wardell, Stephan; Lauck, Sandra; Macle, Laurent; Verma, Atul (28 January 2021). "Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation". New England Journal of Medicine. 384 (4): 305–315. doi:10.1056/NEJMoa2029980.
  37. ^ Kirchhof, Paulus; Camm, A. John; Goette, Andreas; Brandes, Axel; Eckardt, Lars; Elvan, Arif; Fetsch, Thomas; van Gelder, Isabelle C.; Haase, Doreen; Haegeli, Laurent M.; Hamann, Frank; Heidbüchel, Hein; Hindricks, Gerhard; Kautzner, Josef; Kuck, Karl-Heinz; Mont, Lluis; Ng, G. Andre; Rekosz, Jerzy; Schoen, Norbert; Schotten, Ulrich; Suling, Anna; Taggeselle, Jens; Themistoclakis, Sakis; Vettorazzi, Eik; Vardas, Panos; Wegscheider, Karl; Willems, Stephan; Crijns, Harry J.G.M.; Breithardt, Günter (1 October 2020). "Early Rhythm-Control Therapy in Patients with Atrial Fibrillation". New England Journal of Medicine. 383 (14): 1305–1316. doi:10.1056/NEJMoa2019422.
  38. ^ Kar, Saibal; Doshi, Shephal K.; Sadhu, Ashish; Horton, Rodney; Osorio, Jose; Ellis, Christopher; Stone, James; Shah, Manish; Dukkipati, Srinivas R.; Adler, Stuart; Nair, Devi G.; Kim, Jamie; Wazni, Oussama; Price, Mathew J.; Asch, Federico M.; Holmes, David R.; Shipley, Robert D.; Gordon, Nicole T.; Allocco, Dominic J.; Reddy, Vivek Y. (4 May 2021). "Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial". Circulation. 143 (18): 1754–1762. doi:10.1161/CIRCULATIONAHA.120.050117.
  39. ^ Parkash, Ratika; Wells, George A.; Rouleau, Jean; Talajic, Mario; Essebag, Vidal; Skanes, Allan; Wilton, Stephen B.; Verma, Atul; Healey, Jeffrey S.; Sterns, Laurence; Bennett, Matthew; Roux, Jean-Francois; Rivard, Lena; Leong-Sit, Peter; Jensen-Urstad, Mats; Jolly, Umjeet; Philippon, Francois; Sapp, John L.; Tang, Anthony S.L.; MacDonald, Paul; Bennett, Matthew; Chakrabarti, Santabhanu; Yeung-Lai-Wah, John; Ignaszewski, Andrew; Tung, Stanley; Virani, Shahnawaz; Deyell, Marc; Krahn, Andrew; Andrade, Jason; Straatman, Lynn; Toma, Mustafa; Wong, Graham; Wei, Matthew; Greiss, Isabelle; Raymond, Jean-Marc; Coutu, Benoit; Costi, Paolo; Mansour, Fadi; Saint-Phard, Wouter; Denis, Isabelle; Fleury, Julie; Roux, Jean-Francois; Ayala-Paredes, Felix; Badra-Verdu, Mariano; Dussault, Charles; Vachon, Nadia; Dagenais, Véronique; Lamoureux, Caroline; Healey, Jeff; Connolly, Stuart; Ribas, C. Sebastien; Divakaramenon, Syamkumar; Wong, Jorge; Amit, Guy; Meyer, Wendy; Nault, Isabelle; Champagne, Jean; Sarrazin, Jean-Francois; O’Hara, Gilles; Philippon, Francois; Blier, Louis; Plourde, Benoit; Steinburg, Christian; Roy, Karine; Banville, Paule; Ottinger, Brigitte; Boucher, Marie-Eve; Sanchez, Marina; Rivard, Lena; Dubuc, Marc; Guerra, Peter; Dyrda, Katia; Khairy, Paul; Macle, Laurent; Mondesert, Blandine; Roy, Denis; Talajic, Mario; Thibault, Bernard; Tadros, Rafik; Roy, Véronique; Redfearn, Damian; Abdollah, Hoshiar; Baranchuk, Adrian; Michael, Kevin; Simpson, Christopher; Hammond, Sharlene; Wilton, Stephen B.; Clarke, Brian; Morillo, Carlos; Kuriachan, Vikas; Veenhuyzen, George; Quinn, Russell; Exner, Derek; Howlett, Jonathan; McKeage, Jennifer; Leong-Sit, Peter; Gula, Lorne; Skanes, Allan; Manlucu, Jaimie; Tang, Anthony; Klein, George; Wall, Sabrina; El-Sakka, Yomna; Essebag, Vidal; Hadjis, Tom; Bernier, Martin; Joza, Jacqueline; Roux, Jean- Francois; Omelchenko, Alexander; Nascimento, Thais; Rafti, Fiorella; DiStefano, Ida; Parkash, Ratika; Sapp, John; Gray, Chris; Gardner, Martin; Abdel-Wahab, Amir; MacIntyre, Ciorsti J; Rajda, Miroslaw; O’Regan, Patrick; Levins-Lamont, Mary Lee; Lockwood, Evan; Hruczkowski, Tom; Valtuille, Lucas; Chan, Michael; Halenar, Jennifer; McLean, Samantha; Verma, Atul; Khaykin, Yaariv; Nyman, Lynn; Wulffhart, Zaev; Pantano, Alfredo; Tsang, Bernice; Patterson, Sherri; Nath, Annette; Nyman, Lynn; Jolly, Umjeet; Rinne, Clause; Janzen, Irene; Crystal, Eugene; Lashevsky, Ilan; Singh, Sheldon; Tiong, Irving; Syeda, Ambreen; Tremblay, Anyur; Ha, Andrew C. T.; Chauhan, Vijay; Hill, Ann; Nery, Pablo; Birnie, David; Redpath, Calum; Green, Martin; Nair, Girish; Lemery, Robert; Sadek, Mouhannad; MacDonald, Karen; Sterns, Laurence; Novak, Paul; Leather, Richard; Swiggum, Elizabeth; Sikkel, Markus; Lane, Chris; Rakochey, Tanner; Patterson, Caitlin; Luz Leiria, Tiago Luiz; Glotz de Lima, Gustavo; Sant’Anna, Roberto; Dutz, Eduardo; Klein Weber, Cristina; Peixoto Deiro, Aline; Hoscheidt, Laís Machado; Jensen-Urstad, Mats; Linde, Cecile; Saluveer, Ott; Carnlof, Carina; Yu, Chih-Chieh; Chiu, Fu-Chun; Lin, Jiunn-Lee; Huang, Cheng-Yu; Wells, George A.; Theoret-Patrick, Patricia; Ryan, Janine; Tran, My-Linh; Chen, Li; Singh, Sarah; Tang, Anthony; Wells, George; Talajic, Mario; Rouleau, Jean; Parkash, Ratika; Tang, Anthony; Wells, George; Talajic, Mario; Rouleau, Jean; Parkash, Ratika; Verma, Atul; Essebag, Vidal; Birnie, David; Healey, Jeff; Macle, Laurent; Newton, Gary; Coyle, Doug; Skanes, Allan; Wilton, Stephen B.; Wyse, George; Cassidy, Dennis; Thabane, Lehana; Verma, Atul; Morillo, Carlos; Healey, Jeff; Newton, Gary; Sapp, John; Philippon, Francois; Gula, Lorne; Swiggum, Elizabeth; Mielniczuk, Lisa; Nery, Pablo; Nault, Isabelle; Wilton, Stephen B.; Ha, Andrew; Rivard, Lena; Luz Leiria, TIago Luiz; Tung, Stanley; Tzemos, Niko; Mathew, Andrew; Thain, De; Wall, Sabrina; Parkash, Ratika; MacDonald, Anita; Shields, Marcia (7 June 2022). "Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial". Circulation. 145 (23): 1693–1704. doi:10.1161/CIRCULATIONAHA.121.057095.
  40. ^ Wazni, Oussama M.; Dandamudi, Gopi; Sood, Nitesh; Hoyt, Robert; Tyler, Jaret; Durrani, Sarfraz; Niebauer, Mark; Makati, Kevin; Halperin, Blair; Gauri, Andre; Morales, Gustavo; Shao, Mingyuan; Cerkvenik, Jeffrey; Kaplon, Rachelle E.; Nissen, Steven E. (28 January 2021). "Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation". New England Journal of Medicine. 384 (4): 316–324. doi:10.1056/NEJMoa2029554.
  41. ^ Galea, Roberto; De Marco, Federico; Meneveau, Nicolas; Aminian, Adel; Anselme, Frédéric; Gräni, Christoph; Huber, Adrian T.; Teiger, Emmanuel; Iriart, Xavier; Babongo Bosombo, Flora; Heg, Dik; Franzone, Anna; Vranckx, Pascal; Fischer, Urs; Pedrazzini, Giovanni; Bedogni, Francesco; Räber, Lorenz; Valgimigli, Marco (8 March 2022). "Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial". Circulation. 145 (10): 724–738. doi:10.1161/CIRCULATIONAHA.121.057859.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Ewingdo/sandbox/list_of_cardiology_clinical_trials&oldid=1189191044"